Filana Therapeutics (FLNA) Intangibles (2020 - 2024)
Filana Therapeutics (FLNA) posted Intangibles of $37000.0 for Q4 2024, down 46.38% on a QoQ basis from $69000.0 in Q3 2024, and down 78.98% year-over-year from $176000.0 in Q1 2024.
Analysis
Filana Therapeutics (FLNA) Intangibles (2020 - 2024) Analysis & Trends
Filana Therapeutics has reported Intangibles for 5 years, with the latest figure at $37000.0 in Q4 2024.
- On a quarterly basis, Intangibles fell 78.98% year-over-year to $37000.0 in Q4 2024; TTM through Dec 2024 was $37000.0, a 78.98% decrease from a year earlier, with the FY2024 full-year figure at $37000.0, down 78.98% from the prior year.
- Intangibles was $37000.0 for Q4 2024 at Filana Therapeutics, down from $69000.0 in the prior quarter.
- The five-year high for Intangibles was $1.3 million in Q3 2022, with the low at $37000.0 in Q4 2024.
- Average Intangibles over 5 years is $604933.3, with a median of $503000.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Intangibles increased 3.39% in 2022, then slumped 80.04% in 2023.
- Over 5 years, Intangibles stood at $1.3 million in 2020, then dropped by 17.24% to $1.1 million in 2021, then slumped by 42.14% to $622000.0 in 2022, then slumped by 71.7% to $176000.0 in 2023, then slumped by 78.98% to $37000.0 in 2024.
- The last three Intangibles figures came in at $37000.0 (Q4 2024), $69000.0 (Q3 2024), and $82000.0 (Q2 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 20.49 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 14.03 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 412.80 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.31 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 266.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 13.52 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Filana Therapeutics | 38.14 Mn | 38.14 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 37,000.00 |
| Sep 30, 2024 | 69,000.00 |
| Jun 30, 2024 | 82,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Dec 31, 2023 | 176,000.00 |
| Sep 30, 2023 | 268,000.00 |
| Jun 30, 2023 | 387,000.00 |
| Mar 31, 2023 | 503,000.00 |
| Dec 31, 2022 | 622,000.00 |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 859,000.00 |
| Mar 31, 2022 | 940,000.00 |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 1.30 Mn |
| Dec 31, 2020 | 1.30 Mn |